Puma Biotechnology, Inc. (PBYI) Investor Relations Documents

Puma Biotechnology, Inc. (PBYI) investor relations documents from the company's IR site: 12 presentations, 27 press releases; latest deck 2026-08-06. Read in-app with summaries. First-party data.

Q2-2026 Commercial Slides: Puma Biotechnology Q2 2026 commercial update reporting $53.6 million in net NERLYNX revenue, reflecting a 9% year-over-year and 28% sequential increase.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-06Press releasePuma Biotechnology Reports Second Quarter 2026 Financial Results
2026-08-06PresentationQ2-2026 Commercial Slides
2026-08-05Press releasePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
2026-07-23Press releasePuma Biotechnology to Host Conference Call to Discuss Second Quarter 2026 Financial Results
2026-07-10PresentationPuma Biotechnology Corporate Presentation
2026-07-02Press releasePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
2026-06-08PresentationPDF Version
2026-06-03Press releasePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
2026-05-07PresentationQ1-2026 Commercial Slides
2026-05-07Press releasePuma Biotechnology Reports First Quarter 2026 Financial Results
2026-05-06Press releasePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
2026-04-23Press releasePuma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results
2026-04-23Annual report2025 Annual Report
2026-04-02Press releasePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
2026-02-26Press releasePuma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results
2026-02-26PresentationQ4-2025 Commercial Slides
2026-02-23Press releasePDF Version
2026-02-23Press releasePuma Biotechnology to Present at TD Cowen’s 46th Annual Health Care Conference
2026-02-12Press releasePDF Version
Press releaseNews Release
Press releasePuma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
2025-09-08PresentationDownload PDF
2025-09-02Press releasePDF Version
2025-09-02Press releasePuma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference
2025-08-07Presentation2Q Commercial Presentation
2025-05-08Presentation1Q Commercial Presentation
2025-04-28Press releasePDF Version
2025-03-26Press releasePDF Version
2025-02-27Presentation4Q Commercial Presentation
2025-02-26Press releasePDF Version
2025-02-13Press releasePDF Version
2024-11-20Press releasePDF Version
2024-11-20Press releasePuma Biotechnology Announces Initiation of ALISCA™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, HER
2024-11-07Presentation3Q Commercial Presentation
2024-11-07Press releasePuma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results
2024-10-24Press releasePDF Version
2024-09-04PresentationPresentation
2024-09-03Press releasePDF Version
2024-08-01Presentation2Q Commercial Presentation
2024-06-02Press releasePDF Version

PBYI overview · PBYI earnings · PBYI financials · PBYI KPIs · PBYI ownership · PBYI peers · PBYI filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.